Affiliate Faculty
Guido Ferrari
(919) 684-2862
Summary
Dr. Ferrari is currently an Associate Research Professor in the Department of Surgery, Division of Surgical Sciences at Duke University Medical Center. He is directing the ELISPOT, CTL, and ADCC laboratories for the HVTN central laboratory at Duke. He has been serving as a WHO/UNAIDS Vaccine Initiative consultant for the past six years, and coordinated the organization of 5 international workshops for the transfer of ELISpot and ICS technologies to new laboratory sites involved in HIV vaccine studies.
Topics
Locations
Projects
Recent Publications
Neidich, S. D., Fong, Y., Li, S. S., Geraghty, D. E., Williamson, B. D., Young, W. C., … Tomaras, G. D. (2019). Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.. J Clin Invest. https://doi.org/10.1172/JCI126391
Gray, G. E., Huang, Y., Grunenberg, N., Laher, F., Roux, S., Andersen-Nissen, E., … Corey, L. (2019). Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.. Sci Transl Med, 11(510). https://doi.org/10.1126/scitranslmed.aax1880
Li, S. S., Gilbert, P. B., Carpp, L. N., Pyo, C.-W., Janes, H., Fong, Y., … Peng, X. (2019). Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial.. J Virol. https://doi.org/10.1128/JVI.02041-18
Nyanhete, T. E., Frisbee, A. L., Bradley, T., Faison, W. J., Robins, E., Payne, T., … Tomaras, G. D. (2019). HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.. Sci Rep, 9(1). https://doi.org/10.1038/s41598-019-46462-8
Pollara, J., Jones, D. I., Huffman, T., Edwards, R. W., Dennis, M., Li, S. H., … Permar, S. R. (2019). Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.. J Virol, 93(10). https://doi.org/10.1128/JVI.02119-18
Spearman, P., Tomaras, G. D., Montefiori, D. C., Huang, Y., Elizaga, M. L., Ferrari, G., … HVTN 088 Protocol Team and the NIH/NIAID HIV Vaccine Trials Network. (2019). Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period.. J Infect Dis, 219(11), 1755–1765. https://doi.org/10.1093/infdis/jiz008
Pittala, S., Bagley, K., Schwartz, J. A., Brown, E. P., Weiner, J. A., Prado, I. J., … Bailey-Kellogg, C. (2019). Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection.. Mol Syst Biol, 15(5). https://doi.org/10.15252/msb.20188747
Pardi, N., LaBranche, C. C., Ferrari, G., Cain, D. W., Tombácz, I., Parks, R. J., … Weissman, D. (2019). Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques.. Mol Ther Nucleic Acids, 15, 36–47. https://doi.org/10.1016/j.omtn.2019.03.003
Dennis, M., Eudailey, J., Pollara, J., McMillan, A. S., Cronin, K. D., Saha, P. T., … Shen, X. (2019). Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.. J Virol, 93(5). https://doi.org/10.1128/JVI.01783-18
Curtis, A. D., Walter, K. A., Nabi, R., Jensen, K., Dwivedi, A., Pollara, J., … De Paris, K. (2019). Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques.. Aids Research and Human Retroviruses, 35(3), 310–325. https://doi.org/10.1089/aid.2018.0180
